ThinkstockStocks are challenging all-time highs, and this is a shortened week due to Thanksgiving. Investors have to start positioning their assets and portfolios for 2014. 24/7 Wall St. reviews dozens of research…
ThinkstockThe Wall Street firms that handle the bulk of retail accounts are always very careful about recommending stocks priced in the single digits. Typically they are fallen angels, or sometimes just the…
Investors and traders are always looking for new research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh research calls each morning to find great ideas…
thinkstockHere are the five biggest gaining stocks in today’s U.S. markets at closing: Imperial Holdings Inc. (NYSE: IFT) is up 40.5% at $5.59. Kingtone WirelessInfo Solution Holding Ltd. (NASDAQ: KONE) is up…
It may seem hard to believe, but some stocks are expected to rise by 50%, 100%, or even more over the next year. Our own DJIA peak price target is up 11.3%…
U.S. equity markets opened higher this morning on speculation — and some reports — that budget talks in the U.S. were making some progress. Asian markets clearly thought so, with most closing…
The stock market is up Tuesday, with the Dow Jones Industrial Average up 0.43%, the Nasdaq up 0.81%, and the S&P 500 up 0.62%. Today’s winners include a pharmaceutical company reporting a…
The stock market is mixed Tuesday, with the Dow Jones Industrial Average up 0.02%, the Nasdaq down 0.54% and the S&P 500 down 0.20%. Today’s winners include a pharmaceutical company entering into…
The stock market is mixed Tuesday, with the Dow Jones Industrial Average up 0.11%, the Nasdaq down 0.37% and the S&P 500 up 0.05%. Today’s sole winner reported earnings that fell in line with…
As investors brace for Wednesday’s congressional testimony from Federal Reserve Chairman Ben Bernanke, the stock market is up modestly. The Dow Jones Industrial Average is up 0.38%, the Nasdaq is up 0.86% and the…
247sam Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Monday. Amazon.com, Inc. (NASDAQ: AMZN) removed from Conviction Buy List at Evercore. Bank…
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set…
It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. The 2012…
Biotech firm Galena Biopharma Inc. (NASDAQ: GALE) this morning priced a secondary offering of 8.5 million shares at $1.50/share, a discount of nearly 20% to last night’s closing price of $1.87. The…
Paul Ausick Galena Biopharma, Inc. (NASDAQ: GALE) is unknown to most investors out there. The company recently had news about the initiation of its Phase III PRESENT trial for NeuVax (E75 peptide plus GM-CSF)…
Jon C. Ogg 
